Superior vena cava syndrome due to a leiomyosarcoma of the anterior mediastinum: A case report and literature overview

• Leiomyosarcomas are rare causes of superior vena cava syndrome.
• Surgery is the treatment of choice.
• Specific approaches depend on the neoplasm's size and invasion of neighbouring tissues.

INTRODUCTIONLeiomyosarcomas are an infrequent cause of malignant superior vena cava syndrome (VCS).PRESENTATION OF CASEA 51-year old male patient was admitted for a three-day history of dyspnoea, dysphagia and erythema of the head and neck. Computed tomography and magnetic resonance imaging showed a lesion arising on the anterior mediastinum, which was in close proximity with a thrombus in the superior vena cava. Surgical excision was performed, including open resection of the primary tumour and an atrio-innominate vein bypass with 8-mm polytetrafluoroethylene (PTFE). Histology confirmed a leiomyosarcoma and postoperative radiotherapy sessions were performed. Due to evidence of enlargement of the thrombus, a second intervention was undertaken. In this procedure, a remainder of the primary tumour was resected and the superior vena cava reconstructed with an autologous pericardium patch. The patient recovered satisfactorily and was discharged on the seventh postoperative day, with no evidence for relapse after 10 months of follow-up.DISCUSSIONLeiomyosarcomas comprise less than 2% of the tumours of the mediastinum and are a rare cause of paraneoplastic VCS. Male patients in their sixties are most commonly affected. Relapses seem to be common, and thus a careful follow-up is often recommended.CONCLUSIONIn spite of the limited data on the management of thoracic leiomyosarcomas, surgery is currently considered the mainstay of treatment.